Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07112586) titled 'Evaluation of Exosomes Injection in Treatment of Male Androgenetic Alopecia: Clinical and Immunohistochemical Study' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Ain Shams University
Condition:
Androgenetic Alopecia
Intervention:
Drug: Plasma derived exosomes
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: August 30, 2025
Target Sample Size: 15
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/ct2/...